Investing · Page 31

JPMorgan American Trust Reports 2025 Underperformance but Sustained Long-Term Outperformance

JPMorgan American Trust's 2025 lagged behind the S&P 500, but its long-term strategy since 2019 continues to outperform. Analysis and outlook inside.

One Media iP Group Reports 80% EPS Growth and Strategic Refocus in FY2025 Results

One Media iP posts 80% EPS growth in FY2025, driven by cost control and strategic focus. Cash up, debt down, and digital momentum builds with YouTube views soaring 298%.

Berkeley Group Announces Strategic Pause on Land Acquisitions and Rephases 2035 Plan

Berkeley pauses new land buys, focuses on sweating its £2bn land bank. Targets £450m FY26 profit & £300m net cash amid regulatory headwinds.

RC Fornax Reports Strong Trading Momentum with Over £5.1m in FY26 Sales Visibility

RC Fornax defies seasonal slowdown with over £5.1m in FY26 sales visibility, signalling a step-change in order momentum for the defence consultancy.

Fermi Inc. Files First 10-K, Unveiling Ambitious Multi-Gigawatt 'Project Matador' AI Power Campus

Fermi's 10-K unveils Project Matador: a giant 11 GW AI power campus. Bold vision, but success hinges on tenant deals and funding.

TomCo Energy Reports FY 2025 Results Amid Renewed Valkor Partnership and Funding Plans

FY 2025: TomCo cuts losses, revives Valkor ties for Utah drilling, but funding crunch looms with going concern risk.

Anpario Reports 54% Profit Surge and Record Revenue in 2025 Final Results

Discover how Anpario achieved a 54% profit surge and record revenue in 2025, driven by margin expansion and strong US growth.

Videndum Posts Steeper Loss in 2025 Amid Revenue Decline, Completes Major Refinancing

Videndum reports a challenging 2025 with revenue down to £228.3m and losses widening, but completes a major refinancing to slash net debt and reset the balance sheet.

Jubilee Metals Reports Surge in Copper Revenue and Profit in H1 FY2026

70.5% revenue jump & 847.6% profit surge as Jubilee Metals' Zambia-first pivot delivers. H1 FY2026 copper results analysed.

Sabien Technology Reports 51% Revenue Growth and Progress in Green Oil Commercialisation

Sabien Technology's H1 shows 51% revenue growth and strategic momentum in Green Oil commercialisation.

Quantum Helium Reports H1 2025 Results with Strategic Helium Advances

Quantum Helium reports H1 2025 results: revenue up, loss narrowed, and strategic pivot to Colorado helium advances towards a decisive Sagebrush-1 test.

Touchstone Reports 2025 Results Amid Strategic Shift and Liquidity Concerns

Touchstone's 2025 results reveal a strategic pivot to LNG-linked gas and drilling, but a stark liquidity warning overshadows the growth plan due to soaring debt and tight covenants.

Judges Scientific Reports Disappointing FY25 but Hikes Dividend 10% Amid Intact Fundamentals

Judges Scientific's FY25 results show revenue growth but flat profits amid US funding headwinds, yet cash resilience supports a 10% dividend hike and intact long-term fundamentals.

Hilton Food Group Reports Resilient 2025 Results and Strategic Shift to Core Meat Businesses

Hilton Food Group's 2025: Core meat resilient, seafood drags profits. Strategic shift to meat focus with lower 2026 guidance. Expert analysis inside.

Princes Group Reports Robust FY2025 Results with Strong Margin Expansion and Cash Generation Post-LSE Listing

Princes Group reports robust FY2025 with margin expansion and strong cash generation after LSE listing, affirming medium-term growth.

Cirata PLC Reports Record Data Integration Bookings and Strong Growth in FY25 Preliminary Results

Record data integration bookings show Cirata's strong momentum, but cash flow challenges and customer concentration remain key watchpoints for investors.

Metals One Converts US$1.8M Loan into 30% Stake in South African Gold Plant Valued at US$39.6M

Metals One converts a $1.8M loan into a 30% stake in a South African cogeneration plant valued at $39.6M, gaining exposure to power, steam, and gold roasting revenue streams.

Crystal Amber Fund Proposes Management Overhaul and New Investment Strategy

Insight into Crystal Amber's strategic reset: new management, focused on Morphic Medical, with pivotal EGM vote ahead.

Digitalbox plc Reports 2025 Results: Revenue Up 7% but Cash Generation Plummets

Digitalbox's 2025: 7% revenue growth offset by plunging cash flow. Explore the strategic moves and 2026 outlook here.

Rainbow Rare Earths Interim Results Showcase Robust Economics and Rising REE Prices

Rainbow Rare Earths' interim results reveal a successful pilot plant, rising REE prices, and two high-value projects moving from concept to execution.

Bioventix Interim Results Show Five-Fold Jump in Alzheimer's Antibody Royalties

Bioventix's Alzheimer's antibody royalties surge five-fold, while its core business and dividend remain steady. A story of future potential built on solid foundations.

RTW Biotech Opportunities Reports Strong 2025 Results with NAV Growth and FTSE 250 Inclusion

RTW Biotech Opportunities' 2025: NAV up 35.7%, discount narrows to 12%, and FTSE 250 inclusion boosts visibility. A strong rebound year.

Aberdeen Asia Focus Reports Strong Half-Year Results Driven by AI and Electronics Exposure

Big Technologies Reports 12% ARR Growth Amid Litigation Settlement and US Expansion Drive

Big Technologies reports 12% ARR growth, US expansion momentum, and a major litigation settlement in its 2025 results.

Impax Environmental Markets PLC Forced into Exit Tender Offer After Clash with Activist Shareholder Saba Capital

Gaming Realms Reports Record 2025 Results with 10% Revenue and 15% EBITDA Growth

Gaming Realms posts record 2025 revenue, 15% EBITDA growth & a 48% margin. Cash hits £17.8m with another share buyback announced. A year of solid scaling.

Fusion Antibodies Seals £250k IP Deal, Supporting Finn Therapeutics' Fundraising

Fusion Antibodies sells IP for a £250k year-end revenue boost, supporting client Finn Therapeutics' fundraising in tough biotech markets.

PipeHawk PLC Reports 45% Turnover Drop and Subsidiary Insolvency in H1 2026

PipeHawk's H1 FY26 reports a 45% revenue crash, a swing to loss, and the insolvency of subsidiary Adien. The path forward hinges on a crucial asset sale and key orders.

Corcel Completes Major Angola Seismic Campaign, Eyes Drilling as Balance Sheet Strengthens

Corcel completes largest Angola seismic campaign in 15 years, cash position strengthens ahead of key drilling phase.

Genedrive Posts H1 Results with £4.9m Fundraise, Advances NHS and International Commercialisation

Genedrive secures £4.9m funding, eliminates debt, and gains NHS traction for rapid genetic tests, advancing US and international commercialisation.